Advocacy intelligence hub — real-time data for patient organizations
Rifater: FDA approved
Short-course treatment of tuberculosis.
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance1
Rifater
Hoechst Marion Roussel
Rifater
(Rifampin, isoniazid, pyrazinamide)Orphan drugHoechst Marion Roussel